This provider's $8.3M in total Medicare payments ranks in the 88th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 2239% from 2017 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1148% in 2018
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $1.2K | $108.83 | 11.35x | $1.1K | $46.7K | 404 | 363 |
| 2018 | $1.2K | $218.25 | 5.67x | $1.0K | $582.5K | 2.5K | 1.4K |
| 2019 | $298.43 | $81.59 | 3.66x | $216.84 | $1.3M | 7.9K | 5.6K |
| 2020 | $240.25 | $66.64 | 3.61x | $173.61 | $2.0M | 22.3K | 12.2K |
| 2021 | $191.58 | $53.24 | 3.60x | $138.34 | $1.5M | 16.0K | 8.3K |
| 2022 | $143.54 | $59.47 | 2.41x | $84.07 | $1.9M | 22.8K | 4.9K |
| 2023 | $87.65 | $42.18 | 2.08x | $45.47 | $1.1M | 11.1K | 6.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 16.0K | $3.8M | $240.13 | 4.66x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 23.7K | $2.0M | $83.40 | 2.89x |
| G0482 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 3.8K | $723.5K | $192.53 | 4.60x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 3.7K | $420.7K | $113.98 | 3.43x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 13.5K | $333.8K | $24.72 | 1.09x |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 1.3K | $184.2K | $139.78 | 2.06x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 655 | $100.6K | $153.52 | 4.54x |
| 87798 | Detection test for organism | 2.5K | $87.2K | $35.14 | 2.83x |
| 87505 | Detection test for digestive tract pathogen | 582 | $76.8K | $131.98 | 2.23x |
| 87653 | Detection test for Strep (Streptococcus, group B) | 1.6K | $56.5K | $35.25 | 2.12x |
| 87640 | Detection test for Staphylococcus aureus (bacteria) | 1.6K | $56.3K | $35.25 | 2.81x |
| 87556 | Detection test for Mycobacteria tuberculosis (TB bacteria) | 1.3K | $53.2K | $41.28 | 2.03x |
| 87491 | Detection test for chlamydia | 1.5K | $53.2K | $35.31 | 2.13x |
| 87529 | Detection test for herpes simplex virus | 1.5K | $53.1K | $35.26 | 2.12x |
| 87661 | Detection test for Trichomonas vaginalis (genital parasite) | 1.5K | $53.0K | $35.27 | 2.13x |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | 1.2K | $41.0K | $34.79 | 2.05x |
| 87481 | Detection test for candida species (yeast) | 1.1K | $40.0K | $35.41 | 2.34x |
| 87486 | Detection test for Chlamydia pneumoniae | 914 | $31.5K | $34.50 | 2.09x |
| 87581 | Detection test for Mycoplasma pneumoniae (bacteria) | 913 | $31.5K | $34.50 | 2.09x |
| 87541 | Detection test for legionella pneumophila (water borne bacteria) | 706 | $24.9K | $35.26 | 2.11x |
This provider submits charges 3.75 times higher than what Medicare actually pays.
A markup ratio of 3.75x means for every $100 Medicare pays, this provider initially charges $375. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in KS for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Labone Llc | Lenexa, KS | $435.5M | ⚠️ Flagged |
| Laboratory Corporation Of America Holdings | Overland Park, KS | $47.4M | ⚠️ Flagged |
| Eurofins Transplant Genomics, Llc | Lenexa, KS | $44.8M | ✓ Clear |
| Cotton O'neil Clinic Revocable Trust | Topeka, KS | $37.9M | ⚠️ Flagged |
| Biodesix, Inc. | De Soto, KS | $36.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data